Multi-gene Panel Testing
Multi-Gene Panel Testing is a targeted next-generation sequencing assay that simultaneously analyzes a defined set of genes associated with cancer susceptibility or tumor biology to identify pathogenic variants for diagnostic, prognostic, or therapeutic decision-making.
209
Publications
10.6K
Citations
2.1K
Authors
734
Institutions
Publications per year
2017–2026
154
Parents
209
Jie Sun, Hua Meng, Lu Yao et al. · Clinical Cancer Research · 2017 · 270 citations · Full text
Life Sciences, Genetics, Oncology +17
Physicians' Attitudes About Multiplex Tumor Genomic Testing
Stacy W. Gray, Katherine Hicks-Courant, Angel M. Cronin et al. · Journal of Clinical Oncology · 2014 · 247 citations · Full text
1–5 of 209
2.1K
7
h-index
4
h-index
4
h-index
CEINGE Biotecnologie Avanzate Franco Salvatore (Italy), Italy
3 publications · 68 citations
3
h-index
3
h-index
1–5 of 2.1K
734
Stanford University
Stanford, United States
10 h-index
26 publications
2.3K citations
Harvard University
Cambridge, United States
8 h-index
25 publications
1.7K citations
Ambry Genetics (United States)
Aliso Viejo, United States
7 h-index
29 publications
2.1K citations
Myriad Genetics
Salt Lake City, United States
7 h-index
54 publications
4.7K citations
Duke Medical Center
Durham, United States
6 h-index
8 publications
310 citations
Massachusetts General Hospital
Boston, United States
5 h-index
12 publications
2.5K citations

Agostino Gemelli University Polyclinic
Rome, Italy
5 h-index
10 publications
272 citations
Dana-Farber Cancer Institute
Boston, United States
5 h-index
22 publications
790 citations
1–8 of 734
9 publications · 469 citations
9
h-index
GIM · 7 publications · 651 citations
7
h-index
6 publications · 215 citations
6
h-index
6 publications · 176 citations
6
h-index
5 publications · 236 citations
5
h-index
1–5